These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


318 related items for PubMed ID: 17308078

  • 1. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.
    Brueckner B, Stresemann C, Kuner R, Mund C, Musch T, Meister M, Sültmann H, Lyko F.
    Cancer Res; 2007 Feb 15; 67(4):1419-23. PubMed ID: 17308078
    [Abstract] [Full Text] [Related]

  • 2. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.
    Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H.
    Cancer Res; 2007 Nov 01; 67(21):10117-22. PubMed ID: 17974952
    [Abstract] [Full Text] [Related]

  • 3. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T.
    Cancer Res; 2008 Jun 01; 68(11):4123-32. PubMed ID: 18519671
    [Abstract] [Full Text] [Related]

  • 4. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3.
    Tsang WP, Kwok TT.
    Apoptosis; 2008 Oct 01; 13(10):1215-22. PubMed ID: 18758960
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ.
    Cancer Res; 2007 Oct 15; 67(20):9762-70. PubMed ID: 17942906
    [Abstract] [Full Text] [Related]

  • 6. Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing.
    Diederichs S, Haber DA.
    Cancer Res; 2006 Jun 15; 66(12):6097-104. PubMed ID: 16778182
    [Abstract] [Full Text] [Related]

  • 7. Human let-7a miRNA blocks protein production on actively translating polyribosomes.
    Nottrott S, Simard MJ, Richter JD.
    Nat Struct Mol Biol; 2006 Dec 15; 13(12):1108-14. PubMed ID: 17128272
    [Abstract] [Full Text] [Related]

  • 8. Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients.
    Jeong HC, Kim EK, Lee JH, Lee JM, Yoo HN, Kim JK.
    Mol Med Rep; 2011 Dec 15; 4(2):383-7. PubMed ID: 21468581
    [Abstract] [Full Text] [Related]

  • 9. Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma.
    Müller DW, Bosserhoff AK.
    Oncogene; 2008 Nov 06; 27(52):6698-706. PubMed ID: 18679415
    [Abstract] [Full Text] [Related]

  • 10. Let-7a regulation of insulin-like growth factors in breast cancer.
    Lu L, Katsaros D, Zhu Y, Hoffman A, Luca S, Marion CE, Mu L, Risch H, Yu H.
    Breast Cancer Res Treat; 2011 Apr 06; 126(3):687-94. PubMed ID: 20848182
    [Abstract] [Full Text] [Related]

  • 11. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
    Tong AW, Nemunaitis J.
    Cancer Gene Ther; 2008 Jun 06; 15(6):341-55. PubMed ID: 18369380
    [Abstract] [Full Text] [Related]

  • 12. let-7 microRNAs in development, stem cells and cancer.
    Büssing I, Slack FJ, Grosshans H.
    Trends Mol Med; 2008 Sep 06; 14(9):400-9. PubMed ID: 18674967
    [Abstract] [Full Text] [Related]

  • 13. Expression profiling of microRNAs in cancer cells: technical considerations.
    Sioud M, Cekaite L.
    Methods Mol Biol; 2008 Sep 06; 439():179-90. PubMed ID: 18370103
    [Abstract] [Full Text] [Related]

  • 14. Radiation-induced epigenetic alterations after low and high LET irradiations.
    Aypar U, Morgan WF, Baulch JE.
    Mutat Res; 2011 Feb 10; 707(1-2):24-33. PubMed ID: 21159317
    [Abstract] [Full Text] [Related]

  • 15. Slowing down the Ras lane: miRNAs as tumor suppressors?
    Morris JP, McManus MT.
    Sci STKE; 2005 Aug 16; 2005(297):pe41. PubMed ID: 16107327
    [Abstract] [Full Text] [Related]

  • 16. Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer.
    Wang M, Hu Y, Amatangelo MD, Stearns ME.
    Mol Cancer Res; 2011 Jan 16; 9(1):36-50. PubMed ID: 21148031
    [Abstract] [Full Text] [Related]

  • 17. OncomiRs: the discovery and progress of microRNAs in cancers.
    Cho WC.
    Mol Cancer; 2007 Sep 25; 6():60. PubMed ID: 17894887
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family.
    Motoyama K, Inoue H, Nakamura Y, Uetake H, Sugihara K, Mori M.
    Clin Cancer Res; 2008 Apr 15; 14(8):2334-40. PubMed ID: 18413822
    [Abstract] [Full Text] [Related]

  • 19. Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer.
    Suzuki H, Takatsuka S, Akashi H, Yamamoto E, Nojima M, Maruyama R, Kai M, Yamano HO, Sasaki Y, Tokino T, Shinomura Y, Imai K, Toyota M.
    Cancer Res; 2011 Sep 01; 71(17):5646-58. PubMed ID: 21734013
    [Abstract] [Full Text] [Related]

  • 20. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
    Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, Croce CM, Bolondi L, Negrini M.
    Cancer Res; 2007 Jul 01; 67(13):6092-9. PubMed ID: 17616664
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.